New Issue: Barclays sells $21.08 million Capped Leveraged Index Return Notes on S&P Biotechnology

By Devika Patel

Knoxville, Tenn., Nov. 28 – Barclays Bank plc priced $21.08 million of 0% Capped Leveraged Index Return Notes due Jan. 26, 2018 linked to the S&P Biotechnology Select Industry, according to a 424B2 filing with the Securities and Exchange Commission.

The payout at maturity will be par of $10 plus double any index gain, up to a maximum return of 26.25%.

Investors will receive par if the index falls by up to 5% and will lose 1% for every 1% decline beyond 5%.

BofA Merrill Lynch is the agent.

Issuer:	Barclays Bank plc
Issue:	Capped Leveraged Index Return Notes
Underlying index:	S&P Biotechnology Select Industry
Amount:	$21,079,510
Maturity:	Jan. 26, 2018
Coupon:	0%
Price:	Par of $10
Payout at maturity:	Par plus 200% of any index gain, subject to 26.25% maximum return; par if index falls by up to 5%, otherwise 1% loss for every 1% decline beyond 5%
Initial index level:	5,013.70
Pricing date:	Nov. 22
Settlement date:	Nov. 30
Agent:	BofA Merrill Lynch
Fees:	2%
Cusip:	06744M653

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.